Is soluble interleukin-1 receptor antagonist concentration in patients with Graves ' ophthalmopathy neither related to cigarette smoking nor predictive of subsequent response to glucocorticoids?
Our study suggests that circulating soluble interleukin-1 receptor antagonist levels, both at baseline and during glucocorticoid treatment, are neither influenced by cigarette smoking nor predictive of subsequent response to glucocorticoid treatment.
The use of sodium butyrate together with the induction of colorectal cancer was not effective in the prevention of the disease progression.